Keyphrases
Community-acquired Pneumonia
100%
Quinolones
100%
Macrolides
100%
Meta-analysis of Randomized Controlled Trials
100%
Risk Ratio
57%
Adverse Events
28%
Treatment Failure
28%
Gastrointestinal Side Effects
28%
Systematic Meta-analysis
14%
Meta-analysis
14%
Moderate to Severe
14%
Clinical Significance
14%
Lactams
14%
Randomized Controlled Trial
14%
Confidence Interval
14%
Safety Self-efficacy
14%
Relative Efficacy
14%
Event Rate
14%
Treatment-related Adverse Events
14%
Monotherapy
14%
All-cause Mortality
14%
30-day Mortality
14%
Inclusion Criteria
14%
Patient Benefit
14%
Fixed Effects
14%
Risk Analysis
14%
Resistance Development
14%
Clinical Cure
14%
End of Treatment
14%
Safety Implications
14%
Rate-2
14%
Microbiological Failure
14%
Adult Inpatients
14%
Antibiotic Discontinuation
14%
Publication Status
14%
Adult Outpatients
14%
Pneumonia Severity
14%
Ecological Implications
14%
Antibiotic Enhancement
14%
Pharmacology, Toxicology and Pharmaceutical Science
Quinolone Derivative
100%
Macrolide
100%
Randomized Controlled Trial
100%
Community Acquired Pneumonia
100%
Adverse Event
66%
All Cause Mortality
33%
Prematurity
16%
Monotherapy
16%
Beta Lactam
16%
Quinolone
16%